Fundraising Fox

Topos

Brooklyn, US · Founded 2017 · Delaware corporation · 1 known investors

Topos converts cross-border remittances into collateral assets, using remitter funds held in escrow as pledges that back formal credit lines for receivers in underserved regions. The company targets underbanked populations, aiming to provide lower-cost credit through remittance-backed lending.

FintechImpact & Social Good

Founders & leadership

WS
Will ShapiroNamed on SEC filing
MY
Mahir YavuzNamed on SEC filing

Investors · 1

AuxxoBerlin

Reported raises · per SEC filings

Form D private placements

$2.1M disclosed across 2 rounds · 2017–2018

▶$1.9MraisedNov 2018 · 12 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kenneth SchechterDirector
  • Will ShapiroExecutive Officer, Director
  • Mahir M YavuzExecutive Officer, Director
Offering amount
$3.3M
Amount sold
$1.9M
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$197KraisedMay 2017 · 4 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Will ShapiroExecutive Officer, Director
  • Mahir YavuzExecutive Officer, Director
Offering amount
$1M
Amount sold
$197K
First sale
May 2017
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Topos Bio Secures $10.5M to Tackle 'Undruggable' Proteins | Oasys Raises $4.6M to Transform Mental Health Carehealthcareittoday.com · Jan 2026Topos Bio Raises $10.5M Seed to Target ‘Undruggable’ Proteins in Alzheimer’s and Cancerhlth.com · Jan 2026Topos Bio Secures $10.5M to Tackle ‘Undruggable’ Proteins Driving Alzheimer’s and Cancer | WebWirewebwire.com · Jan 2026Topos Bio Emerges from Stealth to Tackle Disordered Proteins with $10.5M and Frontier AIhitconsultant.net · Jan 2026Exclusive: Topos Bio raises $10.5M seed for AI drug discoveryaxios.com · Jan 2026

Frequently asked questions

What does Topos do?
Topos converts cross-border remittances into collateral assets, using remitter funds held in escrow as pledges that back formal credit lines for receivers in underserved regions. The company targets underbanked populations, aiming to provide lower-cost credit through remittance-backed lending.
Who are Topos's investors?
Topos's investors include Auxxo.
How much funding has Topos raised?
Topos has disclosed $2.1M raised across 2 rounds.
Where is Topos headquartered?
Topos is headquartered in Brooklyn, US.